ma Industria
Association of chemical and pharmaceutical industries in the Swiss canton of Ticino 1
Corso Elvezia 16 Casella postale 5130 CH-6901 Lugano
Tel.: +41 91 911 84 86 Fax: +41 91 923 46 36
info@farmaindustriaticino.ch www.farmaindustriaticino.ch
Ticino: the life science valley in the heart of Europe The Association at present counts 27 member companies, with a combined workforce of over 2500 employees and a total annual turnover of approximately 2.3 Billion Swiss Francs (>80% export), accounting for approximately 8% of the cantonal GNP. The actual number of personnel of the companies associated with Farma Industria Ticino averages at 100 employees and is therefore higher than the average associated with the entire industrial sector of Ticino. Several investments accounting for almost a half billion Swiss francs have been planned for Ticino in the next three years, mainly in R&D and innovation. Representing the vast majority of the companies active in this Italian speaking part of Switzerland, FIT has a great network of know-how and access to skilled and qualified, multilingual human resources, due to its strategical and privileged geographical position that makes Ticino a natural connection between northern and southern Europe. In Ticino, the presence of world-class high schools and research institutes integrated into the enterprise system and the proximity to the Swiss and Northern Italy Universities and pharmaceutical expertise provide a significant technical, scientific, logistic and cultural asset. A main area of focus to which Farma Industria Ticino contributes with its own expertise is vocational training. A commitment also based on the constant need to discover and train future co-workers. The Association’s activity in this specific area hinges on the promotion of all training opportunities which are tied to careers in the sector, and targeted at new generations of technicians, organizing introductory courses aimed at young people who are serving apprenticeships in the professions of chemical laboratory technician, biology laboratory technician and manufacturing operators. For the middle management teams, mini-MBA training courses in pharmaceutical management are organized in collaboration with a local university school (SUPSI). Quality, technology, innovation and sustainable growth represent the core assets of our industry. Several companies have been certified, in addition to Swissmedic, by many foreign authorities such as but not limited to US-FDA, Brazilian Anvisa, Japanese PMDA, Korean sFDA and participate in programs such as OSHA, ISO, responsible care and certified sustainability. Activities of our associates range from preclinical and clinical drug development to chemical and formulation process development to industrial manufacturing of different classes of APIs and of a great variety of Drug Products forms. The vast majority of FIT companies also offer services such as Contract Research and Manufacturing Organizations. Attention to quality of life is of paramount importance in Ticino and is reflected in the personal security provided to citizens, the quality of the health system, the efficiency of public transport and of financial services These distinguishing social factors, together with a mild Mediterranean climate and a spectacular natural landscape, represent great assets for all of our associates, our people, our partners and our customers.
2
Locarno Ascona
7
Bellinzona
IRB
Institute for Research in Biomedicine
Fondazione
AGIRE SUPSI
University of Applied Sciences and Arts of Southern Switzerland
USI
University of Southern Switzerland
Lugano
Canton Ticino: platform for international business Located just south of the beautiful Swiss Alps, Ticino is the Italian-speaking region of Switzerland. Its strategic geographic position represents a bridge between northern and southern Europe and between two of the strongest and most dynamic economic areas in Europe: Lombardy – with Milan at its heart – and the Zurich region. In a unique harmony it unites the Swiss accuracy and reliability with the Italian flexibility, resulting in an excellent combination of creativity and sound economic development. Thanks to the mild climate and the attractive landscapes, Ticino is one of the furthermost touristic locations in Switzerland, but at the same time it showcases a wide array of business activities. The local economy ideally balances the industrial and the service sectors. Alongside a leading tertiary sector (Lugano is the third finance market in Switzerland) there is a solid industrial sector with export-oriented, internationally competitive and highly innovative companies. The backbone of the industrial sector, composed by a number of SMEs in the fields of life sciences, mechanics and electronics, has recently been complemented by rising new sectors like renewable energies, advanced logistics, and the fashion industry. In this latter, several top brands found ideal conditions for their regional or worldwide headquarters. In the life sciences field an important role is played by the pharma industry, where top quality niche-producers cover the entire supply chain. The success of the local industrial companies is based, on one hand, on the advantages offered by the “Swiss system” in terms of exceptional political and institutional stability, a competitive and flexible labour market, complete security, and a mild taxation. On the other hand, the availability of highly skilled labour force with exceptional multilingual skills and the opportunity for companies to collaborate with top notch research institutes stimulates the local enterprises to constantly invest in innovation and remain competitive with a cutting edge technology. The local authorities are equipped to advise and support business ventures at their various stages. • Particular attention is paid to the general framework conditions, in order to provide a business-friendly and unbureaucratic environment. In addition, the public administration is always available for a smooth and prompt resolution of any procedural issue that might arise. • The Economic Promotion Agency informs foreign companies about the business opportunities in our region and simplifies their settlement by providing practical and direct support.Start-ups and innovative entrepreneurial projects are supported by the AGIRE Foundation through coaching, technology advisory, networking. AGIRE promotes and fosters the transfer of technology between companies and the academic or research centers. • AGIRE manages the Technology Park (Tecnopolo Ticino that offers office spaces and support to innovative companies targeting international markets from Ticinoso far more than 50 companies have settled there. Additional locations, dedicated to specific business sectors, including biotech and medtech, are in preparation. • TiVENTURE is a newly established venture capital fund that invests in innovative companies with high growth potential strongly collaborating with the local stakeholders of the local innovation ecosystem. • Existing companies and newly settled enterprises active in manufacturing and innovative fields are also offered various direct incentives and support mainly aimed at fostering R&D, innovation and export.
Tecnopolo Ticino Stabile Suglio, Entrata EST, Via Cantonale 18, 6928 Manno - Tel. +41 (0)91 610 27 10, info@agire.ch, www.agire.ch Dipartimento delle finanze e dell’economia Divisione dell’economia
Divisione dell’economia Ufficio per lo sviluppo economico Viale Stefano Franscini 17, CH-6501 Bellinzona - Tel. +41 (0)91 814 35 41, info@copernico.ch, www.copernico.ch
Chiasso
4
2
12
Bellinzona
17 21
11
Locarno
Ascona
1 20 7 16
4 24 27 23 6 9
10 19 18
Lugano
14 13 26 22 5 22 15
25 Chiasso 5
8 3
Farma Industria Ticino (FIT), the association of chemical and pharmaceutical industries in the Swiss Canton of Ticino, is a private organization founded in 1980 with headquarters in Lugano.
Index 1 Alpex Pharma SA, Mezzovico 2 Alpine Foundation for Life Science, Olivone 3 APR Applied Pharma Research SA, Balerna 4 Bracco Suisse SA, Manno 5 Cerbios - Pharma SA, Barbengo 6 Chemo AG, Vienna, Lugano Branch, Lugano 7 Developharma SA, Manno 8 ECSA Chemicals AG, Balerna 9 Fordras SA, a Bioseutica Company, Lugano 10 Ginsana SA, Bioggio 11 Gnosis Bioresearch SA, S. Antonino 12 Helsinn Advanced Synthesis SA, Biasca 13 Helsinn Healthcare SA, Pazzallo 14 IBSA Institut Biochimique SA, Pambio Noranco 15 Ingenus Pharmaceuticals Sagl, Barbengo 16 KerrHawe SA, Bioggio 17 Linnea SA, Riazzino 18 Micro-Macinazione SA, Monteggio 19 Micro-Sphere SA, Ponte Cremenaga 20 Osmopharm SA, Bedano 21 Pharmanalytica SA, Locarno 22 Polichem SA, Pazzallo 23 Refarmed Chemicals SA, Lugano 24 Rivopharm SA, Manno 25 Sintetica SA, Mendrisio 26 Unipharma SA, Barbengo 27 Zambon Svizzera SA, Cadempino
6
Main Activity Main Activity Licensing-In Licensing-In Licensing-Out Licensing-Out Co-development Trading Co-development Drug Product CMO Trading Drug Substance CMO DrugCMO Product CMO Other Activities
● ● ● ●
● ● ● ●
● ● ● ●
● ● ● ●
● ●
●
● ●
Othersupportive CMO Activities Cancer therapy Cardiology Others Cardiovascular CNS Dermatology Oncology Diabetes Dermatology Gastrointestinal Gynaecology Gastrointestinal Oncology Respiratory Ophtalmology Ophtalmology Orthopedics Pain Cancer supportive therapy Respiratory CNS Other therapeutic areas
● ● ●
● ● ● ● ●
● ● ● ● ● ● ● ●
● ● ● ● ● ● ●
● ● ● ● ●
● ● ● ● ● ● ●
● ● ● ● ○ ○ ●
● ● ● ● ● ● ● ● ● ● ●
● ● ● ● ● ● ● ● ● ●
● ● ● ● ● ●
● ○
● ● ● ● ● ● ● ● ● ●
Drug Substance CMO Therapeutic Areas
Therapeutic Areas
Other
Markets
Markets
CH EU EU Top 5 Rest of Europe USA Restand of Canada Europe Japan USA and Canada LATAM Japan MENA LATAM BRICS ASEAN MENA Australia BRICS Other market
ASEAN Australia
7
Alp ex Pha rm Alpex Pharma SA a AP RA ppl ied Alpine Foundation for Life Science Pha Ce r m rbio aR es s-P har PharmaeaResearch rch APR Applied SA ma SA Ch S A em oA G , Vi Bracco Suisse enn SA De a, L vel uga oph no a rm Bra Cerbios-Pharma a S SA nch Em A anu el Ce Vienna, Lugano Branch Chemo eAG, nto For nze dra SA sS A, a Developharma SA Bio Gin seu san tica aS C A ECSA Chemicals AG ompa ny Gn osi sB iore Fordras SA, seaa Bioseutica Company rch SA
Member companies competences
Mic Institut Biochimique SA IBSA roMa cin azi one Ingenus Pharmaceuticals Sagl Mic SA roSph e Linnea SAre SA Os mo pha rm Micro-Macinazione SA SA Pha rm intr aco SA Micro-Sphere Sag l Pol ich e mS Osmopharm A SA Ref arm Polichem ed SA Ch em ica Riv ls S oph A SA Refarmed Chemicals arm SA S inte Rivopharm SA tica SA Un Sintetica SA iph arm aS A Unipharma SA Zam bon Svi zze Zambon Svizzera ra S SA A
He lsin n A SA Ginsana dva nce dS He ynt lsin Gnosis n HBioresearchheSA sis eal SA thc a re S IBS ASynthesis SA A In Advanced Helsinn stit ut B ioc him Lin Helsinn iquSA nea Healthcare eS SA A
● ● ● ●
●
● ● ●
● ●
● ● ● ●
○ ○ ● ●
○ ● ● ●
●
● ●
●
● ● ●
● ● ● ● ● ●
● ● ● ●
● ● ●
●
○ ● ○ ● ●
● ●
● ● ● ● ● ● ● ● ●
● ● ● ●
● ● ● ● ● ●
● ●
○ ○ ● ● ● ● ● ○
● ● ● ● ● ● ● ●
● ● ● ● ● ● ● ●
● ● ● ● ● ●
● ● ●
● ● ● ● ● ● ● ●
● ● ● ● ●
● ●
●
● ● ●
● ● ●
● ●
●
● ●
● ● ● ● ● ● ● ○ ● ●
● ● ● ● ● ● ● ● ● ●
● ● ● ● ● ●
● ● ● ● ● ● ● ● ● ●
● ● ● ● ● ● ● ● ●
● ●
● ● ● ● ● ● ● ● ● ● ●
● ● ● ● ● ● ● ● ● ●
● ● ● ● ● ● ●
● ● ● ● ● ● ● ●
● ● ● ● ● ● ● ● ● ●
● ● ● ● ● ● ● ● ●
● ● ● ● ○ ● ●
● ● ● ● ● ● ● ● ● ●
● ● ● ●
● ●
Yes
● ● ○ ●
●
Partially
● ● ● ●
8
Drug Stages Main Activity Pre-clinical Licensing-In Phase I - Phase III Licensing-Out Registration Market Co-development Generic Plus (505B2) Trading Generic
Drug Product CMO Drug Substance CMO Drug Product Forms Other CMO Activities Aerosol Others Inhaler Life cycle management
Injectable Oral (solid) Oral (liquid) Oncology Spray Dermatology Topical Gastrointestinal Other drug form
Therapeutic Areas
Respiratory Other CMO Activities
Analytical Services Ophtalmology Co-development Cancer supportive therapy Contract Micronization CNS Micronization Other Pre-formulation Spray-Drying Other cmo activities
Markets
EU Top 5 Certifications
Swissmedic Rest of Europe FDA USA and Canada European Medicines Agency Japan Korea FDA ISO 9001 LATAM ISO 14001 MENA PMDA BRICS Anvisa AIFA ASEAN GRI Australia Other Certifications 9
Alp ex Pha rm Alpex Pharma SA a AP RA ppl ied Alpine Foundation for Life Science Pha Ce r m rbio aR es s-P har PharmaeaResearch rch APR Applied SA ma SA Ch S A em oA G , Vi Bracco Suisse enn SA De a, L vel uga oph no a rm Bra Cerbios-Pharma a S SA nch Em A anu el Ce Vienna, Lugano Branch Chemo eAG, nto For nze dra SA sS A, a Developharma SA Bio Gin seu san tica aS C A ECSA Chemicals AG ompa ny Gn osi sB iore Fordras SA, seaa Bioseutica Company rch SA
Member companies competences
● ● ● ● ●
● ○
● ● ● ● ● ●
● ● ● ● ● ●
● ● ● ●
● ● ● ● ●
●
●
●
● ● ●
● ● ● ●
○ ● ● ●
● ● ●
●
●
●
● ● ●
● ● ●
● ○ ● ● ● ●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
Mic Institut Biochimique SA IBSA roMa cin azi one Ingenus Pharmaceuticals Sagl Mic SA roSph e Linnea SAre SA Os mo pha rm Micro-Macinazione SA SA Pha rm intr aco SA Micro-Sphere Sag l Pol ich e mS Osmopharm A SA Ref arm Polichem ed SA Ch em ica Riv ls S oph A SA Refarmed Chemicals arm SA S inte Rivopharm SA tica SA Un Sintetica SA iph arm aS A Unipharma SA Zam bon Svi zze Zambon Svizzera ra S SA A
He lsin n A SA Ginsana dva nce dS He ynt lsin Gnosis n HBioresearchheSA sis eal SA thc a re S IBS ASynthesis SA A In Advanced Helsinn stit ut B ioc him Lin Helsinn iquSA nea Healthcare eS SA A
● ● ● ● ● ●
● ● ● ●
● ● ● ●
● ● ● ●
● ● ○ ●
● ●
● ● ● ● ● ●
● ● ● ● ●
● ●
● ● ● ● ●
● ● ● ●
● ● ● ● ●
● ● ● ● ● ●
●
●
●
● ●
● ● ● ● ● ●
●
● ● ● ●
● ● ○ ● ● ● ●
●
● ● ● ● ●
●
● ● ○
● ● ● ● ● ●
● ● ●
●
● ○
● ● ●
● ● ● ●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
Yes
Partially
○ ● ●
● ●
●
● ●
10
Can he inherit your ambition as well as your wealth? Discover how Credit Suisse can help you plan your wealth for the next generation at credit-suisse.com/successionplanning